NEWRON PHARMACEUTICALS SPA
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Public
- Established
- 1999-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.newron.com
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
Phase 3
Completed
- Conditions
- Idiopathic Parkinson's Disease
- Interventions
- First Posted Date
- 2008-01-31
- Last Posted Date
- 2013-10-29
- Lead Sponsor
- Newron Pharmaceuticals SPA
- Target Recruit Count
- 679
- Registration Number
- NCT00605683
- Locations
- 🇺🇸
Parkinson's Disease and Movement Disorder Center, Boca Raton, Florida, United States
🇺🇸Medical College of Georgia, Augusta, Georgia, United States
🇺🇸Parkinson's Disease and Movement Disorders Center of Albany, Albany, New York, United States
© Copyright 2025. All Rights Reserved by MedPath